Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
China
· Delayed Price · Currency is CNY 54.76
+0.34 (0.62%)
Apr 29, 2026, 3:00 PM CST
Hangzhou Alltest Biotech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,237 | 5,003 | 4,909 | 5,362 | 5,519 | 6,631 | Upgrade
|
| Market Cap Growth | -30.82% | 1.91% | -8.43% | -2.86% | -16.76% | - | Upgrade
|
| Enterprise Value | 2,008 | 2,552 | 2,259 | 2,648 | 2,003 | 4,130 | Upgrade
|
| Last Close Price | 54.76 | 63.89 | 61.00 | 62.75 | 58.28 | 66.65 | Upgrade
|
| PE Ratio | 24.73 | 22.72 | 16.23 | 29.69 | 4.66 | 8.66 | Upgrade
|
| PS Ratio | 4.72 | 5.53 | 5.67 | 7.10 | 1.63 | 3.54 | Upgrade
|
| PB Ratio | 1.09 | 1.27 | 1.26 | 1.40 | 1.32 | 2.03 | Upgrade
|
| P/TBV Ratio | 1.13 | 1.31 | 1.30 | 1.44 | 1.36 | 2.04 | Upgrade
|
| P/FCF Ratio | - | - | 45.10 | - | 5.06 | 8.46 | Upgrade
|
| P/OCF Ratio | - | 24.22 | 14.90 | 216.51 | 4.06 | 7.18 | Upgrade
|
| EV/Sales Ratio | 2.24 | 2.82 | 2.61 | 3.51 | 0.59 | 2.21 | Upgrade
|
| EV/EBITDA Ratio | - | 10.34 | 8.48 | 22.03 | 1.45 | 4.88 | Upgrade
|
| EV/EBIT Ratio | 9.12 | 12.32 | 9.39 | 26.74 | 1.48 | 4.93 | Upgrade
|
| EV/FCF Ratio | - | - | 20.75 | - | 1.84 | 5.27 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.03 | 0.03 | 0.02 | 0.17 | 0.02 | 0.04 | Upgrade
|
| Debt / FCF Ratio | 1.26 | - | 0.04 | - | 0.02 | 0.05 | Upgrade
|
| Net Debt / Equity Ratio | -0.57 | -0.60 | -0.66 | -0.72 | -0.91 | -0.89 | Upgrade
|
| Net Debt / EBITDA Ratio | -10.15 | -9.66 | -9.66 | -23.01 | -2.75 | -3.45 | Upgrade
|
| Net Debt / FCF Ratio | -381.77 | 190.72 | -23.64 | 5.44 | -3.48 | -3.73 | Upgrade
|
| Asset Turnover | 0.22 | 0.22 | 0.21 | 0.17 | 0.78 | 0.73 | Upgrade
|
| Inventory Turnover | 2.56 | 2.64 | 2.25 | 1.99 | 5.41 | 3.33 | Upgrade
|
| Quick Ratio | 10.99 | 8.92 | 9.06 | 10.57 | 7.76 | 4.53 | Upgrade
|
| Current Ratio | 12.36 | 9.88 | 9.91 | 11.53 | 8.20 | 5.14 | Upgrade
|
| Return on Equity (ROE) | 4.55% | 5.62% | 7.85% | 4.51% | 31.85% | 36.06% | Upgrade
|
| Return on Assets (ROA) | 2.65% | 3.07% | 3.62% | 1.41% | 19.45% | 20.29% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.38% | 12.65% | 17.64% | 12.52% | 318.80% | 216.75% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.50% | 5.20% | 6.20% | 2.60% | 32.40% | 25.40% | Upgrade
|
| Earnings Yield | 4.16% | 4.40% | 6.16% | 3.37% | 21.47% | 11.55% | Upgrade
|
| FCF Yield | - | -0.25% | 2.22% | -9.49% | 19.76% | 11.82% | Upgrade
|
| Dividend Yield | 3.68% | - | 4.92% | 2.39% | 11.59% | 4.06% | Upgrade
|
| Payout Ratio | - | 88.61% | 76.92% | 292.78% | 18.20% | 14.08% | Upgrade
|
| Buyback Yield / Dilution | -0.60% | -0.03% | 0.02% | 0.07% | -5.96% | -25.16% | Upgrade
|
| Total Shareholder Return | 3.08% | -0.03% | 4.94% | 2.46% | 5.63% | -21.10% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.